Clinical Trials Browser

Phase 1/2 × Fibrosis × Magnetic Resonance Spectroscopy × Clear all

NCT07042919 2025-06-29

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular